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Abstract 
 
Background: The association between smoking and several health outcomes among those from the 
most deprived communities in the UK, has not previously been detailed. The aim of this study is to 
examine the impact of smoking on health outcomes among individuals from Liverpool, one of the most 
deprived local authorities in England. 
Methods: The Liverpool Lung Project recruited a prospective cohort of 8,753 participants from across 
Liverpool, aged 45-79 years between 1998 and 2008. Participants were followed annually through the 
hospital episode statistics until 31st January 2013. Logistic regression models were used to identify 
health outcomes of smoking. 
Results: From our study population, 5,195 were smokers and 3,558 were non-smokers. Smoking was 
associated with male gender (OR 1.62, 95% CI 1.48-1.77), pneumonia (1.29, 95% CI 1.11-1.50), 
chronic obstructive pulmonary disease (1.26, 95% CI 1.11-1.43), emphysema (5.61, 95% CI 3.58-8.79), 
bronchitis (1.89, 95% CI 1.69-2.13), other cancers (1.72, 95% CI 1.47-2.02), lung cancer (5.55, 95% 
CI 3.51-8.76), diabetes (1.20, 95% CI 1.02-1.42) and cardiovascular disease (1.45, 95% CI 1.25-1.67). 
Conclusions: Smokers from deprived backgrounds in Liverpool appear to have increased risk of 
developing pneumonia, emphysema, chronic obstructive pulmonary disease, bronchitis, lung cancer, 
other types of cancer, cardiovascular disease and diabetes. These findings are in line with the literature 
and may help to inform public health policies and ultimately work towards addressing smoking-related 
health inequalities.  
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Introduction 
Deprivation has been used widely as a surrogate indicator of socio-economic status [1, 2]. In England, 
the Index of Multiple Deprivation (IMD) is a measure of deprivation experienced by people living in 
an area or neighbourhood [3]. It is a robust index that incorporates 37 separate indicators, based on 
weighted data from the following seven domains for quantifying deprivation: income deprivation 
(22.5%), employment deprivation (22.5%), health deprivation and disability (13.5%), education, skills 
and training deprivation (13.5%), barriers to housing and services (9.3%), crime and living environment 
deprivation (9.3%) [3, 4].  
 
Liverpool is one of the most deprived local authorities in the whole of England [3, 5]. Numerous studies 
have reported that individuals from lower socioeconomic backgrounds have markedly poorer health 
outcomes compared to their counterparts from upper socioeconomic backgrounds [6, 7]. Smoking is a 
health inequalities concern, as smoking rates are frequently higher among lower socio-economic groups 
in most developed countries [8-10]. For example, in Great Britain, smoking prevalence among those 
with Managerial and Professional, Intermediate and Routine/Manual statuses was 14%, 20% and 33%, 
respectively [11].  
 
Smoking was attributable to 17% (N = 79,700) of all mortalities in England alone in 2013 and it has 
been estimated that smoking cost the National Health Service (NHS) in England £2.7 billion in 2006 
[12]. Since Doll and Hill [13] first identified the causal link between smoking and lung cancer, research 
continues to identify further associations between smoking, smoking cessation and various other 
diseases [14] and smoking-related mortality [15- 20]. In 2013, it was estimated that smoking was linked 
with 35%, 28% and 13% of all respiratory, cancer and cardiovascular disease mortalities, respectively 
[14]. 
 
In Liverpool, smoking prevalence in adults is 32.5%; substantially higher than the average in England 
(22.8%) [15]. Smoking related deaths in Liverpool are also among the highest rates in England; 
Liverpool’s directly age standardised rate is 428.3 per 100,000 population, aged 35 years and above, 
2012-2014. England’s worst level is 458.1 and average in England is 274.8 [15]. Previous research does 
not typically isolate and explore patterns in smoking-related disease within specific socio-economic 
groups and rather explores it between smokers and non-smokers, across the spectrum of socio-economic 
groups [16]. The benefit of exploring these risks within specific socio-economic groups (such as those 
most deprived) is that we will establish an in-depth understanding of the magnitude of risk between 
smokers and non-smokers among those who are specifically classified as most deprived. This is 
important to consider; a better understanding of risk across a multitude of diseases will help to guide 
and tailor future research and interventions designed to prevent and reduce smoking rates within the 
most deprived communities. For example, we know that completion of smoking cessation behavioural 
support programmes is generally lower for deprived smokers [17]; improved knowledge regarding the 
magnitude of various smoking related risks among the most deprived smokers in developed countries 
could better inform behavioural support programmes by focusing on specific-smoking related diseases 
that are of optimal relevance to the most deprived smokers from developed nations. 
 
 
Method 
Study Population 
This study was performed as part of the Liverpool Lung Project. The objectives, methods, rationale and 
study design have been described previously [18]. The study protocol was approved by the Liverpool 
Research Ethics Committee and all participants provided informed consent in accordance with the 
declaration of Helsinki. 
Briefly, 8,753 randomly selected healthy subjects aged 45-79 years were recruited between 1998 and 
2008 and followed annually for health and mortality outcomes through the Office for National Statistics 
(ONS), Public Health England (the North West Cancer Intelligence Service) and hospital case-note 
review, until 31 January 2013. Because of the objective of this study i.e. to study the effect of smoking 
on various health outcomes, the socioeconomic status of our study population was ascertained from 
anonymised IMD obtained from postcodes provided by participants using a website developed by 
Mimas at the University of Manchester [19]. Using the English IMD 2015, IMD ranks for all 
participants were placed within deciles based on England-wide population data: decile 1 (D1; most 
deprived) = most deprived 10%; decile 2 (D2; 10-20%); decile 3 (D3; 20-30%); decile 4 (D4; 30-40%); 
decile 5 (D5; 40-50%); decile 6 (D6; 50-60%); decile 7 (D6; 60-70%); decile 8 (D8; 70-80%); decile 9 
(D9; 80-90%); decile 10 (D10; least deprived 10%). Our study population fell within the most deprived 
including D1 and D2. 
Data Collection and Extraction of Risk Factors 
Self-reported information on demographics, medical history, family history of cancer and history of 
tobacco consumption were collected using a standardised questionnaire. Information on age, gender, 
smoking duration, prior history of other cancers and prior history of non-malignant lung disease such 
as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, emphysema and 
tuberculosis were extracted from the questionnaire. Smoking duration was measured in years; an ever 
smoker was defined as someone who had smoked at least 100 cigarettes in their lifetime. Previous 
history of cancer (except melanoma) was coded as “yes” or “no”. Information on diagnosis of non-
malignant lung diseases such as asthma, COPD, pneumonia and tuberculosis were coded “yes” or “no”. 
In addition, information about diagnosis of diabetes and cardiovascular disease (CVD) were obtained 
from the Hospital Episode Statistic (HES) database. HES is the national statistical data warehouse for 
the National Health Services that contain details of all admissions, outpatients’ appointments and 
accident and emergences services in England [20]. 
Statistical analyses 
Distribution in health outcomes between smokers and non-smokers was evaluated using Chi-square test 
for categorical variables and t-tests for normally distributed variables. To avoid complete case analysis 
i.e. removing participants in the datasets without complete information in the regression model, 
imputation of missing information was conducted for all missing covariates. Multiple imputation using 
chained equations (MICE) was conducted to impute missing information across multiple variables 
simultaneously [21]. Variable selection in the univariate analysis was informed by the literature and all 
available variables were included in the univariate analysis. Univariate logistic regression was used to 
examine the associations between health outcomes and smoking characteristics. All statistically 
significant covariates (p < 0.05) in the univariate analyses were included in the multivariable logistic 
regression model. Covariates that are not significant in the previous univariate logistic regression were 
subsequently included in multivariable logistic regression, in order to prevent excluding relevant 
covariates that may have been excluded by univariate pre-selection of significant covariates. The final 
multivariable regression was obtained after excluding covariates that were not statistically significant 
at p < 0.05. All analyses were performed using STATA® version 14.2 (StataCorp LP, College Station, 
Texas). 
 
Results 
In our study population (N = 8,753), 5,195 were smokers and 3,558 were non-smokers. Table 1 depicts 
the health outcomes and smoking characteristics of the study population. Smokers were older, more 
often male, and more frequently diagnosed with pneumonia, asthma, tuberculosis, COPD, emphysema, 
bronchitis, lung cancer, other tumours, diabetes and CVD than their non-smoking counterparts. 
 
  
Table 1: Univariate analysis of Health outcomes and smoking characteristics of study population 
Characteristics Smokers 
(n=5195) 
Non-smokers 
(3558) 
Univariate analysis 
OR (95%CI) 
P-values 
Mean Age (SD) 62.0(8.3) 61.1(8.7) 1.01 (1.01-1.02) <0.001 
Gender 
Male 
Female 
 
2724(52.4) 
2471(47.6) 
 
1461(41.1) 
2097(58.9) 
1.52 (1.11-1.45) <0.001 
Smoking duration (SD) 30.8(15.3) - - - 
Prior diagnosis of pneumonia 
No 
Yes 
 
4448(85.6) 
747(14.4) 
 
3183(91.1) 
312(8.9) 
1.71 (1.49-1.97) <0.001 
Prior diagnosis of asthma 
No 
Yes 
 
4272(82.2) 
923(17.8) 
 
3122(87.8) 
436(12.2) 
1.55 (1.37-1.75) <0.001 
Prior diagnosis of tuberculosis 
No 
Yes 
 
5031(96.8) 
164(3.2) 
 
3468(97.5) 
90(2.5) 
1.26 (0.97-1.63) <0.001 
Prior diagnosis of COPD 
No 
Yes 
 
3959(76.2) 
1236(23.8) 
 
3081(86.6) 
477(13.4) 
2.02 (1.80-2.26) <0.001 
Prior diagnosis of Emphysema 
No 
Yes 
 
4919(94.6) 
276(5.3) 
 
3536(99.4) 
22(0.6) 
9.01 (5.82-13.95) <0.001 
Prior diagnosis of Bronchitis 
No 
Yes 
 
3603(69.4) 
1592(30.6) 
 
2960(83.2) 
598(16.8) 
2.19 (1.97-2.43) <0.001 
Prior diagnosis of other tumours 
No 
Yes 
 
4566(76.2) 
629(12.1) 
 
3313(91.9) 
245(8.1) 
1.87 (1.60-2.17) <0.001 
Diagnosis of lung cancer 
No 
Yes 
 
4979(95.8) 
216(4.2) 
 
3537(99.4) 
21(0.6) 
7.30 (4.66-11.46) <0.001 
Prior diagnosis of diabetes 
No 
Yes 
 
4682(90.1) 
513(9.9) 
 
3308(93.0) 
250(7.0) 
1.45 (1.24-1.70) <0.001 
Prior diagnosis of CVD 
No 
Yes 
 
4351(83.8) 
844(16.2) 
 
3208(90.2) 
350(9.8) 
1.78 (1.56-2.03) <0.001 
Abbreviations: SD = Standard deviation; COPD = chronic obstructive pulmonary disease; CVD = 
Cardiovascular disease; *Numbers do not add up to total due to missing data 
 
Table 2 shows the results of the final multivariable logistic regression analysis of all of the health 
outcomes associated with smoking. Male gender, pneumonia, COPD, emphysema, bronchitis, other 
cancers, lung cancer, diabetes and CVD were all associated with smoking. 
 
  
Table 2: Multivariable analysis of health outcomes on smoking characteristics 
Covariates Odds ratios 95% confidence interval P-value 
Sex 1.62 1.48-1.77 <0.001 
Pneumonia 1.29 1.11-1.50 0.001 
COPD 1.26 1.11-1.43 <0.001 
Emphysema 5.61 3.58-8.79 <0.001 
Bronchitis 1.89 1.69-2.13 <0.001 
Other cancers 1.72 1.47-2.02 <0.001 
Lung cancer 5.55 3.51-8.76 <0.001 
Diabetes 1.20 1.02-1.42 0.033 
CVD 1.45 1.25-1.67 <0.001 
Abbreviations: COPD = Chronic Obstructive Pulmonary Disease; CVD=Cardiovascular disease.  
 
 
Discussion 
The current study explored the relationships between smoking and several health outcomes in 
Liverpool, one of the most deprived local authorities in England. In this large prospective population-
based study, smoking was associated with male gender, pneumonia, COPD, emphysema, bronchitis, 
lung cancer, other cancers, diabetes and CVD. The effect of smoking was much more pronounced for 
emphysema OR 5.61 (95% CI 3.58-8.79) and lung cancer 5.55 (95% CI 3.51-8.76) compared to other 
diseases reported. 
 
The association between the effect of smoking on COPD, bronchitis and emphysema was found to be 
consistent with the results of an earlier published meta-analysis by Forey, Thornton and Lee [22]. In 
their study, based on random-effects meta-analyses of most-adjusted RR/ORs, the effect estimates for 
ever smokers compared to never smokers was 2.89 (95% CI 2.63-3.17) for COPD using 129 studies, 
2.69 (95% CI 2.50-2.90) using 114 studies for chronic bronchitis and 4.51 (95% CI 3.38-6.02) for 
emphysema using 28 studies. The effect estimates for both COPD and chronic bronchitis is higher in 
magnitude than in our study. A plausible explanation for this observation is the design of the previous 
study, the large numbers of studies pooled in it and the statistical methodology employed in estimating 
the effect estimates in the meta-analysis. The effect estimate of emphysema in our study was slightly 
higher than that of the aforementioned meta-analysis, which suggests that the most deprived smokers 
are particularly vulnerable to emphysema, compared to their less deprived counterparts. However, there 
is a slight overlap in the effect estimates and confidence interval of both studies which further buttress 
the strong association between smoking and emphysema. Further research is needed to explore the 
relationship between smoking and emphysema in deprived communities to corroborate our results. 
 
Regarding lung cancer, Lee, Foley and Coombs [23] conducted a random-effects meta-analysis, using 
287 studies and reported the relative risk of lung cancer among ever smokers as 5.50 (95% CI 5.07-
5.96). This effect estimate is slightly lower than the effect reported in the current study (OR 5.55, 95% 
CI 3.51-8.76). This suggests that incidence rates may be substantially higher among ever smokers in 
the current study, potentially due to socio-economic status. In another study, Sidorchuk, Agardh, 
Aremu, Hallqvist, Allebeck and Moradi [24] undertook a systematic review and meta-analysis to 
examine the relationship between socio-economic status and lung cancer incidence. They found that the 
greatest effect was present for studies exploring educational attainment and lung cancer incidence was 
significantly higher among those with the lowest level of educational attainment RR 1.61 (95% CI 1.40-
1.85). Furthermore, studies investigating occupation and also, income displayed increased lung cancer 
incidence among the least affluent groups compared to the most affluent; RR 1.48 (95% CI 1.34-1.65), 
RR 1.37 (95% CI 1.06-1.77), respectively. The current study provides further insight into this 
relationship, as deprivation was considered and, more specifically, the English IMD. It is currently 
unclear if further factors might implicate the observed relationship between smoking, deprivation and 
lung cancer. 
 
We also found that smoking was associated with other types of cancers (OR 1.72, 95%CI 1.47-2.02). 
This result was in accordance with earlier studies that have implicated smoking with 14 different types 
of cancer including nose and sinus, mouth and upper throat, larynx, oesophagus, liver, pancreas, 
stomach, kidney, bowel, ovary, bladder, leukaemia and cervical cancer, excluding lung cancer [25]. 
However, the current study provides an overview of the magnitude of risk among smokers from the 
most deprived communities, compared to their non-smoking counterparts. 
 
In the present study, smoking was associated with diabetes (OR 1.21, 95% CI 1.02-1.43). This 
observation is also consistent with the literature, although there is currently limited research on the 
effect of smoking on diabetes among deprived communities and this finding adds to our knowledge. 
The Health Professionals' Follow-up Study showed that the risk for diabetes among men who smoked 
25 cigarettes or more per day was RR 1.94 (95% CI 1.25-3.03) compared with non-smokers [26]. Other 
studies have also reported an association between smoking and diabetes in Japanese, United States and 
Chinese populations [26-31] . 
  
In our study, we observed that smoking was associated with CVD (OR 1.46, 95% CI 1.26-1.69). 
Smoking is regarded as the most preventable cause of cardiovascular morbidity and mortality [32] and 
there is overwhelming evidence from epidemiological studies showing association between smoking 
and CVD [33, 34]. In a recent study, Ehteshami-Afshar, Momenan, Hajshekholeslami, Azizi and 
Hadaegh [35] evaluated the impact of smoking status on CVD among Iranian men. In this prospective 
study, 3059 men aged ≥30 years, free of CVD at baseline were evaluated for a median of 9.3 years 
follow-up. Being a past smoker significantly increased the risk of CVD events HR 2.42 (95% CI 1.28–
0.56), however, smoking had no effect on coronary heart disease (CHD) events, total and CVD 
mortality. Being a current smoker (more than 10 cigarettes a day) dramatically increased the risk of 
CVD/CHD events and total/CVD mortality. However, smoking less than 10 cigarettes per day was 
associated with a lower level of increased CVD risk 2.12 (95% CI 1.14–3.95) and its mortality 4.57 
(95% CI 1.32–15.79). The current study adds to these findings as we report an estimation of CVD risk 
among smokers from a deprived population in the UK, providing an estimate of how the level of risk 
might differ to some other populations previously reported. 
 
The current study provides a risk estimation for smoking-related disease among a deprived community 
in a developed country, however, other potentially mediating factors now need to be explored in addition 
to smoking, to fully understand the association between deprivation and smoking-related disease. As 
described, Sidorchuk, Agardh, Aremu, Hallqvist, Allebeck and Moradi [24] found that lung cancer 
incidence was highest among those with the lowest level of educational attainment, and those from the 
least affluent groups regarding occupation and income, even in some cases where smoking was 
controlled for. In considering these results with previous research regarding health outcomes and 
smoking, it should also be noted that some differences may be attributed to inconsistencies in 
international clinical practice over recent decades e.g. discrepancies in diagnosis definitions or 
misdiagnosis, or varying measures. However, further research is needed to fully understand the extent 
of smoking-related risk among deprived communities and to consider new strategies that might reduce 
this health inequality. 
 
This research is novel in that it is focused specifically on a large cohort obtained from Liverpool, which 
was reported as one of the most deprived local authorities in England. To the best of our knowledge, 
there are currently no large cohort studies that have explored the relationship between smoking and 
smoking-related disease in deprived population from a developed country. The findings provide insight 
regarding smoking-related risks among specifically, the most deprived group within a developed 
country, providing better understanding of the magnitude of risk within such populations. In addition,  
we included data on a variety of health outcomes to truly explore the extent to which smoking affects 
health outcomes in a socio-economic deprived population.  
 
Strengths of our study include the large number of participants, prospective study design, the long 
follow-up period, the reliability of the health outcome measures, the population-based setting and 
multiple imputation of missing data, which minimises bias. The findings of our study should be viewed 
in the light of some limitations. First, we used the IMD as a surrogate for socioeconomic status. IMD 
is not a perfect measure of deprivation. However, it represents a commendable advance in regard to the 
development of methods used to quantify deprivation in the English population [4]. Second, our study 
was based on a specific population in Liverpool which may limit generalisability. However, the city of 
Liverpool can be compared to other cities in England and in other developed countries so our study 
could be generalised both to the English and other communities in developed countries. Third, Smoking 
data was also gathered by extensively trained and closely supervised interviewers who used 
standardised questionnaires. Despite this, there is a possibility that recall and other biases may have 
influenced the results, as participants were required to report on smoking behaviours over a number of 
decades previous to the interview.  
 Since the results suggest that health outcomes are particularly prominent amongst ever smokers 
compared to never smokers within deprived communities, we should consider future directions. As 
described, further analyses may benefit from the integration of additional variables associated with both 
smoking and socio-economic status, to explore any mediating effect which is independent of smoking. 
In doing so, it may be possible to identify other avenues by which health inequalities could be reduced. 
In comparison to previous data, it seems that health outcomes remain substantially poorer among 
smokers and those from less affluent socio-economic groups to present day within a developed country 
such as England; which leads us to explore how far the health inequalities margin has narrowed and 
what more can be done. A review by Hiscock, Bauld, Amos, Fidler and Munafo [17] suggested that 
differences in smoking prevalence between socioeconomic groups could be the result of factors 
including: lower social support for quitting, poorer motivation to quit, greater addiction to tobacco, 
decreased likelihood of completing a pharmacotherapy or behaviour support programme for quitting 
smoking, psychological differences e.g. lower self-efficacy. The current study adds to understanding of 
the magnitude to which individuals from the most deprived communities in developed countries exhibit 
smoking-related risk. A better understanding of the risks associated with smoking among the most 
deprived communities and consideration of psychosocial factors associated with smoking prevalence 
among the most deprived individuals from developed nations, could help to inform more tailored and 
robust smoking cessation communications; ultimately, tailored communications have been referred to 
as the most promising approach to smoking cessation interventions [36].   
What is already known on this subject: 
 
 Smoking has been associated with deprivation and smoking-related risk is higher among 
deprived populations. 
 Previous research on smoking often focuses on specific outcomes in diverse socioeconomic 
status, as opposed to focusing on specific socio-economic groups. 
 Exploration of a range of smoking-related risks within a specifically deprived population, will 
improve understanding of risk and help to inform future smoking cessation approaches.  
 
 
What this study adds: 
 
 Deprived smokers are substantially more at risk of developing lung cancer, other types of 
cancers, pneumonia, bronchitis, emphysema, CVD, COPD and diabetes, than their non-
smoking counterparts. 
 Risk estimates for some smoking-related disease among participants in the current study were 
observed to be substantially higher than some reported elsewhere, which has implications for 
the tailoring of future smoking cessation interventions. 
 Further research is required to fully understand other substantial factors in the relationship 
between smoking, deprivation and disease; this would help to inform public health policies that 
could help narrow this prominent health inequality. 
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